Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT02918058
Eligibility Criteria:
Inclusion Criteria:
Participants will represent a consecutive series of persons.
* Eligible participants include those who are:
* aged 65 years or older;
* taking 5 or more medications; and
* admitted to the inpatient medical ward at any of the study sites.
* Patients who are cognitively impaired or otherwise unable to provide consent will still be included as this sub-population of patients may be at greatest risk of ADEs because of their communication problems. Tri-council ethics guidelines (Canada) deem that this sub-population should not be excluded from interventions that potentially provide direct benefit to the participant due to the inability to provide informed consent (Article 4.5, Tri-Council Policy Statement 2008). For these patients, the family/proxy will authorize study participation pending the return of patient capacity to consent.
Patients who are ultimately discharged from non-study units during their hospitalization will be excluded unless that unit is a transitional care, rehabilitation, or post-acute care unit used to bridge the gap between acute medical hospitalization and community services.
Exclusion Criteria:
* patients expected to be transferred to another acute care hospital, a non-medical unit, or a palliative care unit;
* patients who normally live outside of the province of hospitalization;
* patients not enrolled in (or eligible for) the provincial drug plans;
* patients previously enrolled in the study;
* patients or proxy not able to speak English or French;
* no means of contacting patient or proxy post-discharge;
* patients expected to die within 30 days and whose level of care has been declared to be palliative will be maintained in the study but will be excluded from select secondary outcomes.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
120 Years
Study:
NCT02918058
Study Brief:
Protocol Section:
NCT02918058